CA1027293A - Polymeres greffes avec des molecules anti-inflammatoires - Google Patents
Polymeres greffes avec des molecules anti-inflammatoiresInfo
- Publication number
- CA1027293A CA1027293A CA175,363A CA175363A CA1027293A CA 1027293 A CA1027293 A CA 1027293A CA 175363 A CA175363 A CA 175363A CA 1027293 A CA1027293 A CA 1027293A
- Authority
- CA
- Canada
- Prior art keywords
- dans
- par
- une
- que
- est
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
- C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F18/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid
- C08F18/02—Esters of monocarboxylic acids
- C08F18/04—Vinyl esters
- C08F18/10—Vinyl esters of monocarboxylic acids containing three or more carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PRECIS DE LA DIVULGATION:
Procédé de préparation de nouveaux polymères à activi-té anti-inflammatoire caractérisé par le fait que, dans un pre-mier stade, on polymérise en présence d'un catalyseur un monomè-re porteur d'une fonction réactive permettant de former avec les molécules anti-inflammatoires à fonction acide carboxylique ou ses dérivés des liaisons covalentes, ledit monomère étant poly-mérisé seul ou en présence d'autres monomères et que, dans un deuxième stade, on fait réagir le polymère formé avec une molé-cule anti-inflammatoire dans une proportion correspondant au po-lymère que l'on souhaite obtenir. Une variante consiste, dans un premier stade, à préparer un dérivé insaturé de la molécule anti-inflammatoire à fonction acide carboxylique et, dans un deuxième stade, à homopolymériser ou copolymériser en présence d'un catalyseur dé polymérisation ledit dérivé insaturé seul ou en présence d'autres monomères. L'invention a également pour ob-jet ces nouveaux polymères à activité anti-inflammatoire ainsi obtenus.
Procédé de préparation de nouveaux polymères à activi-té anti-inflammatoire caractérisé par le fait que, dans un pre-mier stade, on polymérise en présence d'un catalyseur un monomè-re porteur d'une fonction réactive permettant de former avec les molécules anti-inflammatoires à fonction acide carboxylique ou ses dérivés des liaisons covalentes, ledit monomère étant poly-mérisé seul ou en présence d'autres monomères et que, dans un deuxième stade, on fait réagir le polymère formé avec une molé-cule anti-inflammatoire dans une proportion correspondant au po-lymère que l'on souhaite obtenir. Une variante consiste, dans un premier stade, à préparer un dérivé insaturé de la molécule anti-inflammatoire à fonction acide carboxylique et, dans un deuxième stade, à homopolymériser ou copolymériser en présence d'un catalyseur dé polymérisation ledit dérivé insaturé seul ou en présence d'autres monomères. L'invention a également pour ob-jet ces nouveaux polymères à activité anti-inflammatoire ainsi obtenus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU65621A LU65621A1 (fr) | 1972-06-29 | 1972-06-29 | |
LU65622A LU65622A1 (fr) | 1972-06-29 | 1972-06-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1027293A true CA1027293A (fr) | 1978-02-28 |
Family
ID=26640110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA175,363A Expired CA1027293A (fr) | 1972-06-29 | 1973-06-29 | Polymeres greffes avec des molecules anti-inflammatoires |
Country Status (11)
Country | Link |
---|---|
US (1) | US3946035A (fr) |
JP (1) | JPS5415705B2 (fr) |
AT (1) | AT336269B (fr) |
CA (1) | CA1027293A (fr) |
CH (2) | CH579599A5 (fr) |
DE (1) | DE2333211A1 (fr) |
ES (2) | ES416403A1 (fr) |
FR (1) | FR2190454B1 (fr) |
GB (1) | GB1442640A (fr) |
NL (1) | NL7309151A (fr) |
SE (2) | SE419992B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4107290A (en) * | 1972-06-29 | 1978-08-15 | L'oreal | Anti-solar polymers, method of making the same and cosmetic compositions containing the same |
US4701521A (en) * | 1978-07-17 | 1987-10-20 | The Trustees Of Boston University | Method of effecting cellular uptake of molecules |
JPS55500053A (fr) * | 1978-01-16 | 1980-01-31 | ||
FR2629084B1 (fr) * | 1988-03-28 | 1990-11-30 | Essilor Int | Polymeres supports de produits actifs relargables, de type hydrogel, compositions correspondantes et leur procede de preparation |
US5753246A (en) * | 1995-11-20 | 1998-05-19 | Peters; Marlin W. | Packaged germicidal towelette, sanitation kit and method for promoting hygiene |
US5952392A (en) * | 1996-09-17 | 1999-09-14 | Avanir Pharmaceuticals | Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition |
US6440980B1 (en) * | 1996-09-17 | 2002-08-27 | Avanir Pharmaceuticals | Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
NZ526821A (en) * | 2001-01-18 | 2005-02-25 | Genzyme Corp | Ionene polymers and their use as antimicrobial agents |
EA200400535A1 (ru) * | 2001-10-16 | 2005-06-30 | Аванир Фармасютикалз | ПОДАВЛЕНИЕ ВИРУСОВ n-ДОКОСАНОЛОМ |
WO2004046109A2 (fr) * | 2002-11-19 | 2004-06-03 | Genzyme Corporation | Oligomeres and polymeres d'ionene |
WO2012134965A1 (fr) * | 2011-03-25 | 2012-10-04 | The Trustees Of Columbia University In The City Of New York | Modulateurs de canaux chlorure et de transporteurs de chlorure pour thérapie dans les maladies des muscles lisses |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2888380A (en) * | 1954-11-05 | 1959-05-26 | Merck & Co Inc | S-ethyl cysteine compositions for combatting tubercle bacilli |
FR92221E (fr) * | 1965-03-03 | 1968-10-11 | Oreal | Nouveaux copolymères et applications de ces copolymères à la cosmétique |
LU54202A1 (fr) * | 1967-07-28 | 1969-03-24 | Oreal | Procédé de préparation de nouveaux copolymères et compositions cosmétiques contenant ces copolymères |
US3535337A (en) * | 1967-07-26 | 1970-10-20 | Merck & Co Inc | 1-p-chlorobenzoyl-2-methyl-3-metallo-methyl indoles |
US3798235A (en) * | 1967-12-09 | 1974-03-19 | Sumitomo Chemical Co | Novel method for producing 1-phenyl-3-indolylacetic acid derivatives |
DE1930306A1 (de) * | 1968-06-18 | 1970-01-02 | Colgate Palmolive Co | Substantive Lichtschutzmittel |
-
1973
- 1973-06-27 US US05/374,060 patent/US3946035A/en not_active Expired - Lifetime
- 1973-06-28 ES ES416403A patent/ES416403A1/es not_active Expired
- 1973-06-28 FR FR7323703A patent/FR2190454B1/fr not_active Expired
- 1973-06-29 SE SE7309249A patent/SE419992B/xx unknown
- 1973-06-29 AT AT578673A patent/AT336269B/de not_active IP Right Cessation
- 1973-06-29 CH CH952273A patent/CH579599A5/xx not_active IP Right Cessation
- 1973-06-29 CA CA175,363A patent/CA1027293A/fr not_active Expired
- 1973-06-29 NL NL7309151A patent/NL7309151A/xx not_active Application Discontinuation
- 1973-06-29 JP JP7300373A patent/JPS5415705B2/ja not_active Expired
- 1973-06-29 DE DE19732333211 patent/DE2333211A1/de active Granted
- 1973-06-29 CH CH219976A patent/CH578021A5/xx not_active IP Right Cessation
- 1973-06-29 GB GB3115173A patent/GB1442640A/en not_active Expired
-
1975
- 1975-11-03 ES ES442306A patent/ES442306A1/es not_active Expired
-
1977
- 1977-07-25 SE SE7708537A patent/SE7708537L/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE2333211A1 (de) | 1974-04-04 |
DE2333211C2 (fr) | 1988-09-08 |
CH579599A5 (fr) | 1976-09-15 |
ES442306A1 (es) | 1977-10-01 |
FR2190454B1 (fr) | 1976-12-31 |
FR2190454A1 (fr) | 1974-02-01 |
SE419992B (sv) | 1981-09-07 |
ATA578673A (de) | 1976-08-15 |
CH578021A5 (fr) | 1976-07-30 |
JPS5415705B2 (fr) | 1979-06-16 |
ES416403A1 (es) | 1976-07-01 |
NL7309151A (fr) | 1974-01-02 |
SE7708537L (sv) | 1977-07-25 |
JPS4958195A (fr) | 1974-06-05 |
AU5763373A (en) | 1975-01-09 |
AT336269B (de) | 1977-04-25 |
US3946035A (en) | 1976-03-23 |
GB1442640A (en) | 1976-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1027293A (fr) | Polymeres greffes avec des molecules anti-inflammatoires | |
CA2150229C (fr) | Esters nitriques a activite pharmacologique et procede de preparation de ces esters | |
US5498729A (en) | Prodrug compositions | |
KR100269727B1 (ko) | 2-(2,6-디-할로페닐아미노)페닐아세트산의 유도체의 니트릭에스테르 및 그들의 제조방법 | |
JP2866744B2 (ja) | 眼の炎症障害を処置するための3‐ベンゾイルフェニル酢酸誘導体を含む局所的に投与可能な組成物 | |
WO2003014073A1 (fr) | Composes derives d'acides gras preparation et utilisations | |
FR2514348A1 (fr) | Nouveaux sels d'acides carboxyliques, procede pour leur preparation et compositions pharmaceutiques les contenant | |
WO2005077898A1 (fr) | Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique | |
EP0218622B1 (fr) | Amides de l'acide para-methoxycinnamique et leurs utilisation comme filtres solaires | |
EP0376852B1 (fr) | Microgranulés chargés en une substance active, constitués essentiellement d'un triglycéride d'acides gras saturés et leur utilisation par voie topique dans le domaine thérapeutique | |
EP1222916A2 (fr) | Utilisation de dérivés amino-alcools à fonction urée comme hydratant dans des compositions cosmétiques ou dermatologiques | |
FR2522324A1 (fr) | Pyrrole-acetamides, leur procede de preparation et composition therapeutique les contenant | |
EP0487620A1 (fr) | Nouveaux derives d'amino-acides, leur procede de preparation et leur application therapeutique. | |
WO1999018093A1 (fr) | Nouveaux derives 3,4-diarylthiazolin-2-one ou -2-thione, leurs procedes de preparation et leurs utilisations en therapeutique | |
WO1998011080A1 (fr) | Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique | |
WO1998005643A1 (fr) | Nouveaux derives diarylmethylene carbocycliques, leurs procedes de preparation et leurs utilisations en therapeutique | |
US5350768A (en) | Derivatives of cysteine | |
FR2920769A1 (fr) | Nouveaux derives de n-phenyl acetamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant | |
CA2722840A1 (fr) | Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique | |
KR20210124311A (ko) | 티아졸린 항통각과민제로 통증을 치료하는 방법 | |
CA2858312A1 (fr) | Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras en tant qu'analgesique, antalgique ou en tant que retardant sexuel | |
EP0677288B1 (fr) | Composition cosmétique ou pharmaceutique contenant un carbamate d'alkyle en tant qu'agent hydratant | |
BE1000477A3 (fr) | Compositions pharmaceutiques pour l'administration par absorption percutanee et procede pour les preparer. | |
CA1039301A (fr) | Procede de preparation de nouveaux derives de monohydroxyphenethylamines et leurs sels | |
CH665645A5 (fr) | Derives de dipeptides et leur procede de preparation. |